Join to View Full Profile
10 Congress St.Suite 511Pasadena, CA 91105
Phone+1 626-867-6700
Fax+1 626-867-6770
Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Paul Lin is an Obstetrics and Gynecology specialist based in Pasadena, CA, with a subspecialty in Gynecologic Oncology. He completed his residency in Obstetrics and Gynecology at the University of California (San Francisco) and a fellowship in Gynecologic Oncology at the University of Texas MD Anderson Cancer Center. He is currently a staff physician at Huntington Health as part of Huntington Cancer Center, an affiliate of Cedars-Sinai. Dr. Lin is experienced in gynecologic oncology and minimally invasive gynecologic surgery. He has co-authored several publications in reputable journals, with topics covering cancer treatments and therapies, which have been cited by other publications multiple times.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 1994 - 1997
University of California (San Francisco)Residency, Obstetrics and Gynecology, 1990 - 1994
University of Mississippi School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1992 - 2025
TX State Medical License 1995 - 1999
HI State Medical License 1992 - 1994
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Publications & Presentations
PubMed
- 21 citationsA phase I trial of intraperitoneal nab-paclitaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavityMihaela C. Cristea, Paul Frankel, Timothy W. Synold, Saul E. Rivkin, Dean Lim
Cancer Chemotherapy and Pharmacology. 2019-01-08 - 35 citationsL1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in...Hao Hong, Christine E. Brown, Julie R. Ostberg, Saul J. Priceman, Wen-Chung Chang
Plos One. 2016-01-13 - 19 citationsCervical conization of adenocarcinoma in situ: a predicting model of residual diseaseKatherine E. Tierney, Paul S. Lin, Charles A. Amezcua, Koji Matsuo, Wei Ye
American Journal of Obstetrics and Gynecology. 2014-04-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
